Guo Sun-Wei, Wang Yuedong
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisc. 53226-0509, USA.
Gynecol Obstet Invest. 2006;62(3):121-30. doi: 10.1159/000093019. Epub 2006 Apr 28.
The 2004 American College of Obstetrics and Gynecology clinical management guideline states that the prevalence of endometriosis is approximately 33% in women with chronic pelvic pain (CPP). This estimate came from a review showing that 28% of adult women with CPP were found to have endometriosis. The prevalence of 28% in adult women was arrived based on a compilation of 11 published studies. Yet even within the 11 studies, the reported prevalence of endometriosis varies wildly, ranging from 2 to 74%. Such an astounding variation or heterogeneity raises the question whether it is appropriate to use a single prevalence of endometriosis for all women with CPP.
We sought to identify possible sources of heterogeneities in the estimation of prevalence of endometriosis in women with CPP. We included more studies that reported prevalence estimates than the review, and examined the effect of sample size and the year of publication on the heterogeneity.
The year of publication is positively associated with the prevalence estimate, which may indicate an increasing awareness of various appearances of endometriosis, or the prevalence of endometriosis may have increased among women with CPP. An alternative analysis with removal of four studies reporting highest prevalence estimates indicated that sample size is negatively associated with the prevalence estimates while the year of publication became only marginally significant.
There are identifiable sources of heterogeneity in prevalence estimates, with the year of publication, sample size, and difference in evaluation of CPP being three apparent sources. Having a single prevalence estimate for all women with CPP may be too simplistic at best. The true prevalence is very likely to be higher than 33%.
2004年美国妇产科医师学会临床管理指南指出,慢性盆腔疼痛(CPP)女性中子宫内膜异位症的患病率约为33%。这一估计来自一项综述,该综述显示,28%的成年CPP女性被发现患有子宫内膜异位症。成年女性中28%的患病率是基于11项已发表研究的汇总得出的。然而,即使在这11项研究中,报道的子宫内膜异位症患病率也差异极大,从2%到74%不等。如此惊人的差异或异质性引发了一个问题,即对所有CPP女性使用单一的子宫内膜异位症患病率是否合适。
我们试图确定CPP女性子宫内膜异位症患病率估计中可能的异质性来源。我们纳入了比该综述更多报告患病率估计的研究,并研究了样本量和发表年份对异质性的影响。
发表年份与患病率估计呈正相关,这可能表明对子宫内膜异位症各种表现的认识有所提高,或者CPP女性中子宫内膜异位症的患病率可能有所增加。一项排除四项报告最高患病率估计的研究的替代分析表明,样本量与患病率估计呈负相关,而发表年份仅具有微弱的显著性。
患病率估计中存在可识别异质性来源,发表年份、样本量和CPP评估差异是三个明显的来源。对所有CPP女性采用单一的患病率估计充其量可能过于简单化。真实患病率很可能高于33%。